178.85
+3.92%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ICU Medical
From its filings with the US Securities and Exchange Commission
ICU Medical is based in San Clemente, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ICUI. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $2.23bn and net income of $732,000. At that date it held total assets of $4.05bn and shareholders' equity of $2.12bn. By business, Infusion Consumables [Member] brought in 49.7% of revenue, followed by Infusion Systems [Member] at 30.7% and Vital Care at 19.6%. By region, UNITED STATES accounted for 60.8%, followed by EMEA [Member] at 18.5% and APAC [Domain] at 10.4%.
ICU develops, manufactures and sells innovative medical products used in infusion therapy, vascular access, and vital care applications. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU's product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions offered on behalf of our joint venture; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products.
Headquartered in San Clemente, California, ICU was founded in 1984. Our primary customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. Since our inception we have grown organically and through acquisitions.
In February 2017, we acquired Pfizer Inc.’s (“Pfizer”) Hospira Infusion Systems (“HIS”) business. The HIS acquisition complemented our legacy non-dedicated infusion sets and oncology business by expanding our product portfolio to include a complete intravenous infusion therapy product-line from IV solutions to IV pumps to non-dedicated infusion sets.
Quoted from its 10-K, filed 19 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 31 Mar 1992
- Employees
- 13,000
- Website
- icumed.com ↗
- Head office
- 951 CALLE AMANECER, SAN CLEMENTE, CA, 92763-6212
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Vivek JainChairman of the Board, Chief Executive Officer, since 2014$6.5m
- Mr. Daniel WoolsonPresident$2.1m
- Mr. Brian BonnellChief Financial Officer, Treasurer$4.0m
- Mr. Christian VoigtlanderChief Operating Officer$4.0m
- Ms. Virginia SanzoneCorporate Vice President, General Counsel, Secretary$2.9m
- Mr. David GreenbergLead Independent Director$296,019
- Mr. Donald AbbeyIndependent Director$255,019
- Ms. Elisha FinneyIndependent Director$265,019
- Ms. Laurie HernandezIndependent Director$255,019
- Mr. David HoffmeisterIndependent Director$282,019
- Ms. Kolleen KennedyIndependent Director$255,019
- Mr. John MillsInvestor Relations, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 44
- Environment
- 23
- Social
- 65
- Governance
- 46
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ICU Medical Inc has a strong market presence and brand reputation in the medical device industry.
- The company offers a wide range of innovative and high-quality medical products, meeting the diverse needs of healthcare providers.
- ICU Medical Inc has a robust distribution network, enabling efficient delivery of its products worldwide.
Weaknesses
- ICU Medical Inc relies heavily on a limited number of key suppliers, which could result in potential supply chain disruptions.
- The company may face challenges in keeping up with rapidly evolving healthcare regulations and compliance requirements.
- ICU Medical Inc has high research and development costs, which can impact its profitability.
Opportunities
- The increasing global demand for healthcare services presents an opportunity for ICU Medical Inc to expand its market share.
- Advancements in medical technology open doors for the development and introduction of new and improved medical devices.
- ICU Medical Inc can explore strategic partnerships or acquisitions to enhance its product portfolio and market reach.
Threats
- Intense competition in the medical device industry puts pressure on pricing and reduces profit margins for ICU Medical Inc.
- Changes in healthcare policies and reimbursement systems can impact the demand and adoption of medical devices.
- Economic downturns and fluctuations in exchange rates can affect the company's financial performance in international markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.